<DOC>
	<DOCNO>NCT02724644</DOCNO>
	<brief_summary>The study evaluate safety , effectiveness , immunogenicity EN3835 treatment adult woman Edematous Fibrosclerotic Panniculopathy ( Commonly known Cellulite ) .</brief_summary>
	<brief_title>EN3835 Treatment Edematous Fibrosclerotic Panniculopathy ( Commonly Known Cellulite )</brief_title>
	<detailed_description />
	<mesh_term>Edema</mesh_term>
	<criteria>Be female ≥18 year age At Screening visit , least 1 quadrant : score 3 4 ( moderate severe ) report subject ( PR PCSS ) , score 3 4 ( moderate severe ) report Investigator ( CRPCSS ) , Hexsel CSS score great 13 At Day 1 visit , assign quadrant : score 3 4 ( moderate severe ) report subject ( PRPCSS ) , score 3 4 ( moderate severe ) report Investigator ( CRPCSS ) , Hexsel CSS score great 13 Be willing apply sunscreen select treatment quadrant exposure sun participate study ( ie , screen end study ) . Be judge good health , base upon result medical history , physical examination , laboratory profile screen Have negative urine pregnancy test screen use effective contraception method ( eg , abstinence , intrauterine device [ IUD ] , hormonal [ estrogen/progestin ] contraceptive , double barrier method ) least 1 menstrual cycle prior study enrollment duration study ; menopausal define 12 month amenorrhea absence biological physiological cause , determine investigator ; postmenopausal least 1 year ; surgically sterile . Be willing able cooperate requirement study Voluntarily sign date inform consent agreement approve Institutional Review Board/Independent Ethics Committee/Human Research Ethics Committee ( IRB/IEC/HREC ) . Be able read , complete understand Patient Reported Outcomes rating instrument English Has follow condition : Thyroid disease , unless control medication ≥6 month Uncontrolled diabetes mellitus , determine Investigator Uncontrolled hypertension , determine Investigator Vascular disorder ( eg , phlebitis varicose vein ) area treat Cushing 's disease and/or use systemic corticosteroid total daily dose great 5 mg prednisone ( equivalent ) History low extremity thrombosis postthrombosis syndrome Documented autoimmune disorder lupus erythematosus , rheumatoid arthritis Inflammation active infection area treat Active cutaneous alteration area treat include rash , eczema , psoriasis skin cancer History keloidal scar abnormal wound heal Coagulation disorder Taking medication chronic anticoagulation ( except ≤150 mg aspirin daily )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>